These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33794872)

  • 21. A
    Verma A; Minnier J; Wan ES; Huffman JE; Gao L; Joseph J; Ho YL; Wu WC; Cho K; Gorman BR; Rajeevan N; Pyarajan S; Garcon H; Meigs JB; Sun YV; Reaven PD; McGeary JE; Suzuki A; Gelernter J; Lynch JA; Petersen JM; Zekavat SM; Natarajan P; Dalal S; Jhala DN; Arjomandi M; Gatsby E; Lynch KE; Bonomo RA; Freiberg M; Pathak GA; Zhou JJ; Donskey CJ; Madduri RK; Wells QS; Huang RDL; Polimanti R; Chang KM; Liao KP; Tsao PS; Wilson PWF; Hung AM; O'Donnell CJ; Gaziano JM; Hauger RL; Iyengar SK; Luoh SW;
    Am J Respir Crit Care Med; 2022 Nov; 206(10):1220-1229. PubMed ID: 35771531
    [No Abstract]   [Full Text] [Related]  

  • 22. A common MUC5B promoter polymorphism and pulmonary fibrosis.
    Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
    N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
    Ley B; Newton CA; Arnould I; Elicker BM; Henry TS; Vittinghoff E; Golden JA; Jones KD; Batra K; Torrealba J; Garcia CK; Wolters PJ
    Lancet Respir Med; 2017 Aug; 5(8):639-647. PubMed ID: 28648751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
    Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
    Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human
    Tharavecharak S; Fujimoto H; Yasuma T; D'Alessandro-Gabazza CN; Toda M; Tomaru A; Saiki H; Uemura M; Kogue Y; Ito T; Furuhashi K; Okano T; Takeshita A; Nishihama K; Ono R; Hataji O; Nosaka T; Kobayashi T; Gabazza EC
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-exome sequencing identifies susceptibility genes and pathways for idiopathic pulmonary fibrosis in the Chinese population.
    Fang C; Huang H; Feng Y; Zhang Q; Wang N; Jing X; Guo J; Ferianc M; Xu Z
    Sci Rep; 2021 Jan; 11(1):1443. PubMed ID: 33446833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotype-Phenotype Relationships in Inheritable Idiopathic Pulmonary Fibrosis: A Greek National Cohort Study.
    Manali ED; Kannengiesser C; Borie R; Ba I; Bouros D; Markopoulou A; Antoniou K; Kolilekas L; Papaioannou AI; Tzilas V; Tzouvelekis A; Daniil Z; Fouka E; Papakosta D; Xyfteri A; Karakatsani A; Loukides S; Korbila I; Tomos IP; Konstantinidis AK; Gogali A; Steiropoulos P; Papanikolaou IC; Bazaka C; Haritou A; Vassilakopoulos T; Maniati M; Kagouridis K; Markozannes E; Bouros E; Rampiadou C; Kounti G; Trachalaki A; Dimeas I; Karampitsakos T; Lyberopoulos P; Malamadakis N; Spyropoulou S; Revy P; Lainey E; Dieudé P; Rebah K; Ménard C; Oudin C; Masson C; Plessier A; Legendre M; Nathan N; Coulomb-L'Hermine A; Clement A; Amselem S; Boileau C; Crestani B; Papiris S;
    Respiration; 2022; 101(6):531-543. PubMed ID: 35078193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.
    Goos T; Verleden SE; De Sadeleer LJ; Van Herck A; Sacreas A; Vanstapel A; Kaes J; Geudens V; Aelbrecht C; Ruttens D; Lambrechts D; Vermeer S; Ceulemans LJ; Van Raemdonck DE; Godinas L; Yserbyt J; Vanaudenaerde BM; Verleden GM; Vos R; Wuyts WA
    Transpl Int; 2022; 35():10159. PubMed ID: 35651878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis.
    Lee MG; Lee YH
    Inflamm Res; 2015 Jun; 64(6):463-70. PubMed ID: 25926289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of common genetic variants in idiopathic pulmonary fibrosis survival.
    Mota PC; Soares ML; Vasconcelos CD; Ferreira AC; Lima BA; Manduchi E; Moore JH; Melo N; Novais-Bastos H; Pereira JM; Guimarães S; Moura CS; Marques JA; Morais A
    J Mol Med (Berl); 2022 Sep; 100(9):1341-1353. PubMed ID: 35986225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort.
    Wang H; Zhuang Y; Peng H; Cao M; Li Y; Xu Q; Xin X; Zhou K; Liang G; Cai H; Dai J
    Sci Rep; 2019 Oct; 9(1):15307. PubMed ID: 31653936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site Polymorphism.
    Chung JH; Peljto AL; Chawla A; Talbert JL; McKean DF; Rho BH; Fingerlin TE; Schwarz MI; Schwartz DA; Lynch DA
    Chest; 2016 May; 149(5):1215-22. PubMed ID: 26836909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MUC5B expression and location in surfactant protein C mutations in children.
    Liptzin DR; Watson AM; Murphy E; Kroehl ME; Dishop MK; Galambos C; Evans CM; Schwarz MI; Deterding RR; Schwartz DA
    Pediatr Pulmonol; 2015 Dec; 50(12):1270-6. PubMed ID: 25858779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between FCGR2A rs1801274 and MUC5B rs35705950 variations and pneumonia susceptibility.
    Shi X; Ma Y; Li H; Yu H
    BMC Med Genet; 2020 Apr; 21(1):71. PubMed ID: 32252656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities.
    Moll M; Peljto AL; Kim JS; Xu H; Debban CL; Chen X; Menon A; Putman RK; Ghosh AJ; Saferali A; Nishino M; Hatabu H; Hobbs BD; Hecker J; McDermott G; Sparks JA; Wain LV; Allen RJ; Tobin MD; Raby BA; Chun S; Silverman EK; Zamora AC; Ortega VE; Garcia CK; Barr RG; Bleecker ER; Meyers DA; Kaner RJ; Rich SS; Manichaikul A; Rotter JI; Dupuis J; O'Connor GT; Fingerlin TE; Hunninghake GM; Schwartz DA; Cho MH
    Am J Respir Crit Care Med; 2023 Oct; 208(7):791-801. PubMed ID: 37523715
    [No Abstract]   [Full Text] [Related]  

  • 36. Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes.
    Wei R; Li C; Zhang M; Jones-Hall YL; Myers JL; Noth I; Liu W
    Transl Res; 2014 May; 163(5):494-502. PubMed ID: 24434656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
    Juge PA; Lee JS; Ebstein E; Furukawa H; Dobrinskikh E; Gazal S; Kannengiesser C; Ottaviani S; Oka S; Tohma S; Tsuchiya N; Rojas-Serrano J; González-Pérez MI; Mejía M; Buendía-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou K; van Moorsel CHM; van der Vis J; de Man YA; Grutters JC; Wang Y; Borie R; Wemeau-Stervinou L; Wallaert B; Flipo RM; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Marchand-Adam S; Frazier A; Richette P; Allanore Y; Sibilia J; Dromer C; Richez C; Schaeverbeke T; Lioté H; Thabut G; Nathan N; Amselem S; Soubrier M; Cottin V; Clément A; Deane K; Walts AD; Fingerlin T; Fischer A; Ryu JH; Matteson EL; Niewold TB; Assayag D; Gross A; Wolters P; Schwarz MI; Holers M; Solomon JJ; Doyle T; Rosas IO; Blauwendraat C; Nalls MA; Debray MP; Boileau C; Crestani B; Schwartz DA; Dieudé P
    N Engl J Med; 2018 Dec; 379(23):2209-2219. PubMed ID: 30345907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis.
    Peljto AL; Steele MP; Fingerlin TE; Hinchcliff ME; Murphy E; Podlusky S; Carns M; Schwarz M; Varga J; Schwartz DA
    Chest; 2012 Dec; 142(6):1584-1588. PubMed ID: 22576636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of MUC5B gene on antisynthetase syndrome.
    López-Mejías R; Remuzgo-Martínez S; Genre F; Pulito-Cueto V; Rozas SMF; Llorca J; Fernández DI; Cuesta VMM; Ortego-Centeno N; Gómez NP; Mera-Varela A; Martínez-Barrio J; López-Longo FJ; Mijares V; Lera-Gómez L; Usetti MP; Laporta R; Pérez V; Gafas AP; González MAA; Calvo-Alén J; Romero-Bueno F; Sanchez-Pernaute O; Nuno L; Bonilla G; Balsa A; Hernández-González F; Grafia I; Prieto-González S; Narvaez J; Trallero-Araguas E; Selva-O'Callaghan A; Gualillo O; Castañeda S; Cavagna L; Cifrian JM; González-Gay MA
    Sci Rep; 2020 Jan; 10(1):1415. PubMed ID: 31996780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population.
    Borie R; Crestani B; Dieude P; Nunes H; Allanore Y; Kannengiesser C; Airo P; Matucci-Cerinic M; Wallaert B; Israel-Biet D; Cadranel J; Cottin V; Gazal S; Peljto AL; Varga J; Schwartz DA; Valeyre D; Grandchamp B
    PLoS One; 2013; 8(8):e70621. PubMed ID: 23940607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.